Production of prostaglandin E2 induced by cigarette smoke modulates tissue factor expression and activity in endothelial cells

FASEB Journal

Volumn 29, Issue 9, 2015, Pages 4001-4010

  Amadio, Patrizia ^a,b   Baldassarre, Damiano ^a,b   Tarantino, Eva ^a   Zacchi, Elena ^a   Gianellini, Sara ^b   Squellerio, Isabella ^b   Amato, Mauro ^b   Weksler, Babette B ^c   Tremoli, Elena ^a,b   Barbieri, Silvia S ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Ep1 receptor; Prostanoids; SIRT1; Thrombosis

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; BLOOD CLOTTING FACTOR 10A; BUTAPROST; CARBACYCLIN; CIGARETTE SMOKE; INTERLEUKIN 1BETA; MICROPARTICLE ASSOCIATED TISSUE FACTOR; MISOPROSTOL; PROCOAGULANT; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; RESVERATROL; SC 51089; SIRTUIN 1; SMALL INTERFERING RNA; THROMBOPLASTIN; UNCLASSIFIED DRUG; 6-ISOPROPOXY-9-OXOXANTHENE-2-CARBOXYLIC ACID; HYDRAZINE DERIVATIVE; IL1B PROTEIN, HUMAN; IL1B PROTEIN, MOUSE; OXAZEPINE DERIVATIVE; SIRT1 PROTEIN, HUMAN; SIRT1 PROTEIN, MOUSE; XANTHONE DERIVATIVE;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTIC TISSUE; ARTERY THROMBOSIS; ARTICLE; CAROTID ARTERY LIGATION; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FRAMINGHAM RISK SCORE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LYMPHOCYTE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOKING; UPREGULATION; WESTERN BLOTTING; WILD TYPE; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BLOOD; CLINICAL TRIAL; FEMALE; GENE EXPRESSION REGULATION; HEART MUSCLE; METABOLISM; MIDDLE AGED; PATHOLOGY; THROMBOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; DINOPROSTONE; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYDRAZINES; INTERLEUKIN-1BETA; MALE; MICE; MIDDLE AGED; MYOCARDIUM; OXAZEPINES; SIRTUIN 1; SMOKING; THROMBOPLASTIN; THROMBOSIS; XANTHONES;

EID: 84952719107     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-268383     Document Type: Article

References (50)

1. Yang, Y. M., and Liu, G. T. (2004) Damaging effect of cigarette smoke extract on primary cultured human umbilical vein endothelial cells and its mechanism. Biomed. Environ. Sci. 17, 121-134
2. Vayssier-Taussat, M., Camilli, T., Aron, Y., Meplan, C., Hainaut, P., Polla, B. S., and Weksler, B. (2001) Effects of tobacco smoke and benzo[a]pyrene on human endothelial cell and monocyte stress responses. Am. J. Physiol. Heart Circ. Physiol. 280,H1293-H1300
3. Barbieri, S. S., Ruggiero, L., Tremoli, E., and Weksler, B. B. (2008) Suppressing PTEN activity by tobacco smoke plus interleukin-1beta modulates dissociation of VE-cadherin/beta-catenin complexes in endothelium. Arterioscler. Thromb. Vasc. Biol. 28,732-738
4. Messner, B., and Bernhard, D. (2014) Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 34, 509-515
5. Barbieri,S.S.,andWeksler,B.B. (2007) Tobacco smoke cooperates with interleukin-1beta to alter beta-catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo. FASEB J. 21, 1831-1843
6. Li,M.,Yu,D.,Williams,K.J.,andLiu,M.L.(2010) Tobacco smoke induces the generation of procoagulant microvesicles from human monocytes/macrophages. Arterioscler. Thromb. Vasc. Biol. 30, 1818-1824
7. Mackman, N. (2004) Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler. Thromb. Vasc. Biol. 24, 1015-1022
8. Swystun,L.L.,Mukherjee,S.,Levine,M.,andLiaw,P.C.(2011)The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animalbased and cell-based models. J. Thromb. Haemost. 9, 767-775
9. Hölschermann, H., Terhalle, H. M., Zakel, U., Maus, U., Parviz, B., Tillmanns, H., and Haberbosch, W. (1999) Monocyte tissue factor expression is enhanced in women who smoke and use oral contraceptives. Thromb. Haemost. 82, 1614-1620
10. Barbieri, S. S., Zacchi, E., Amadio, P., Gianellini, S., Mussoni, L., Weksler, B. B., and Tremoli, E. (2011) Cytokines present in smokers' serum interact with smoke components to enhance endothelial dysfunction. Cardiovasc. Res. 90, 475-483
11. Barbieri, S. S., Amadio, P., Gianellini, S., Zacchi, E., Weksler, B. B., and Tremoli, E. (2011) Tobacco smoke regulates the expression and activity of microsomal prostaglandin E synthase-1: role of prostacyclin and NADPH-oxidase. FASEB J. 25, 3731-3740
12. Smith, J. P., Haddad, E. V., Downey, J. D., Breyer, R. M., and Boutaud, O. (2010) PGE2 decreases reactivity of human platelets by activating EP2 and EP4. Thromb. Res. 126, e23-e29
13. Petrucci,G.,DeCristofaro,R.,Rutella,S.,Ranelletti,F.O.,Pocaterra,D., Lancellotti, S., Habib, A., Patrono, C., and Rocca, B. (2011) Prostaglandin E2 differentially modulates human platelet function through the prostanoidEP2andEP3receptors.J. Pharmacol. Exp. Ther. 336,391-402
14. Moreno, J. J. (2009) Differential effects of arachidonic and eicosapentaenoic acid-derived eicosanoids on polymorphonuclear transmigration across endothelial cell cultures. J. Pharmacol. Exp. Ther. 331, 1111-1117
15. Heptinstall, S., Espinosa, D. I., Manolopoulos, P., Glenn, J. R., White, A. E., Johnson, A., Dovlatova, N., Fox, S. C., May, J. A., Hermann, D., Magnusson, O., Stefansson, K., Hartman, D., and Gurney, M. (2008) DG-041 inhibits the EP3 prostanoid receptor-a new target for inhibition of platelet function in atherothrombotic disease. Platelets 19, 605-613
16. Gross, S., Tilly, P., Hentsch, D., Vonesch, J. L., and Fabre, J. E. (2007) Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors. J. Exp. Med. 204,311-320
17. Norel, X. (2007) Prostanoid receptors in the human vascular wall. ScientificWorldJournal 7, 1359-1374
18. Gillum, M. P., Erion, D. M., and Shulman, G. I. (2011) Sirtuin-1 regulation of mammalian metabolism. Trends Mol. Med. 17,8-13
19. Barbieri, S. S., Amadio, P., Gianellini, S., Tarantino, E., Zacchi, E., Veglia,F.,Howe,L.R.,Weksler,B.B.,Mussoni,L.,andTremoli,E. (2012) Cyclooxygenase-2-derived prostacyclin regulates arterial thrombus formation by suppressing tissue factor in a sirtuin-1-dependent-manner. Circulation 126, 1373-1384
20. Breitenstein,A.,Stein,S.,Holy,E.W.,Camici,G.G.,Lohmann,C., Akhmedov, A., Spescha, R., Elliott, P. J., Westphal, C. H., Matter, C. M., Lüscher, T. F., and Tanner, F. C. (2011) Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells. Cardiovasc. Res. 89, 464-472
21. Barua, R. S., Sy, F., Srikanth, S., Huang, G., Javed, U., Buhari, C., Margosan, D., and Ambrose, J. A. (2010) Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation. Arterioscler. Thromb. Vasc. Biol. 30,75-79
22. Ambrose, J. A., and Barua, R. S. (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol. 43,1731-1737
23. Barua,R.S.,Ambrose,J.A.,Eales-Reynolds,L.J.,DeVoe,M.C.,Zervas, J. G., and Saha, D. C. (2002) Heavy and light cigarette smokers have similar dysfunction of endothelial vasoregulatory activity: an in vivo and in vitro correlation. J. Am. Coll. Cardiol. 39, 1758-1763
24. Reinhardt, C., von Brühl, M. L., Manukyan, D., Grahl, L., Lorenz, M., Altmann, B., Dlugai, S., Hess, S., Konrad, I., Orschiedt, L., Mackman, N., Ruddock, L., Massberg, S., and Engelmann, B. (2008) Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J. Clin. Invest. 118, 1110-1122
25. Kotani, T., Kobata, A., Nakamura, E., Amagase, K., and Takeuchi, K. (2006) Roles of cyclooxygenase-2 and prostacyclin/IP receptors in mucosal defense against ischemia/reperfusion injury in mouse stomach. J. Pharmacol. Exp. Ther. 316,547-555
26. Cavar, I., Kelava, T., Vukojeví, K., Saraga-Babí, M., and Culo, F. (2010) The role of prostaglandin E2 in acute acetaminophen hepatotoxicity in mice. Histol. Histopathol. 25, 819-830
27. Zeng, L., An, S., and Goetzl, E. J. (1998) EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells. J. Pharmacol. Exp. Ther. 286, 1420-1426
28. Pavlovic, S., Du, B., Sakamoto, K., Khan, K. M., Natarajan, C., Breyer, R. M., Dannenberg, A. J., and Falcone, D. J. (2006) Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages. J. Biol. Chem. 281, 3321-3328
29. Rao, R., Redha, R., Macias-Perez, I., Su, Y., Hao, C., Zent, R., Breyer, M. D., and Pozzi, A. (2007) Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. J. Biol. Chem. 282, 16959-16968
30. Abramovitz, M., Adam, M., Boie, Y., Carrière, M., Denis, D., Godbout, C., Lamontagne, S., Rochette, C., Sawyer, N., Tremblay, N. M., Belley, M., Gallant, M., Dufresne, C., Gareau, Y., Ruel, R., Juteau, H., Labelle, M., Ouimet, N., and Metters, K. M. (2000) The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim. Biophys. Acta 1483,285-293
31. Yang, C., Kwan, Y. W., Au, A. L., Poon, C. C., Zhang, Q., Chan, S. W., Lee, S. M., and Leung, G. P. (2010) 14,15-Epoxyeicosatrienoic acid induces vasorelaxation through the prostaglandin EP(2) receptors in rat mesenteric artery. Prostaglandins Other Lipid Mediat. 93,44-51
32. Nakamaru, Y., Vuppusetty, C., Wada, H., Milne, J. C., Ito, M., Rossios, C., Elliot, M., Hogg, J., Kharitonov, S., Goto, H., Bemis, J. E., Elliott, P., Barnes, P. J., and Ito, K. (2009) A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. FASEB J. 23, 2810-2819
33. Caito, S., Rajendrasozhan, S., Cook, S., Chung, S., Yao, H., Friedman, A. E., Brookes, P. S., and Rahman, I. (2010) SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J. 24, 3145-3159
34. Arunachalam, G., Yao, H., Sundar, I. K., Caito, S., and Rahman, I. (2010) SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: role of resveratrol. Biochem. Biophys. Res. Commun. 393,66-72
35. Barua, R. S., and Ambrose, J. A. (2013) Mechanisms of coronary thrombosis in cigarette smoke exposure. Arterioscler. Thromb. Vasc. Biol. 33, 1460-1467
36. Matetzky, S., Tani, S., Kangavari, S., Dimayuga, P., Yano, J., Xu, H., Chyu, K. Y., Fishbein, M. C., Shah, P. K., and Cercek, B. (2000) Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaquethrombogenicity.Circulation 102,602-604
37. Sambola, A., Osende, J., Hathcock, J., Degen, M., Nemerson, Y., Fuster, V., Crandall, J., and Badimon, J. J. (2003) Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 107,973-977
38. Ruggeri, Z. M. (2000) Old concepts and new developments in the study of platelet aggregation. J. Clin. Invest. 105,699-701
39. Gross, N. D., Boyle, J. O., Morrow, J. D., Williams, M. K., Moskowitz, C. S., Subbaramaiah, K., Dannenberg, A. J., and Duffield-Lillico, A. J. (2005) Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers. Clin. Cancer Res. 11, 6087-6093
40. Duffield-Lillico, A. J., Boyle, J. O., Zhou, X. K., Ghosh, A., Butala, G. S., Subbaramaiah, K., Newman, R. A., Morrow, J. D., Milne, G. L., and Dannenberg, A. J. (2009) Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway. Cancer Prev. Res. (Phila.) 2, 322-329
41. Boie, Y., Stocco, R., Sawyer, N., Slipetz, D. M., Ungrin, M. D., Neuschäfer-Rube, F., Püschel, G. P., Metters, K. M., and Abramovitz, M. (1997) Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur. J. Pharmacol. 340,227-241
42. Menter, D. G., and Dubois, R. N. (2012) Prostaglandins in cancer cell adhesion, migration, and invasion. Int. J. Cell Biol. 2012, 723419
43. Kaneshiro, T., Okumura, M., Maalouf, S., Uflacker, A., Maruyama, T., and Kawamori, T. (2009) Inhibition of prostaglandin E(2) signaling through the EP(1) receptor does not affect prostacyclin production in human endothelial cells. Prostaglandins Other Lipid Mediat. 90, 31-36
44. Schug, T. T., Xu, Q., Gao, H., Peres-da-Silva, A., Draper, D. W., Fessler, M. B., Purushotham, A., and Li, X. (2010) Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Mol. Cell. Biol. 30, 4712-4721
45. Csiszar, A., Labinskyy, N., Podlutsky, A., Kaminski, P. M., Wolin, M. S., Zhang, C., Mukhopadhyay, P., Pacher, P., Hu, F., de Cabo, R., Ballabh, P., and Ungvari, Z. (2008) Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am. J. Physiol. Heart Circ. Physiol. 294,H2721-H2735
46. Rajendrasozhan, S., Yang, S. R., Edirisinghe, I., Yao, H., Adenuga, D., and Rahman, I. (2008) Deacetylases and NF-kappaB in redox regulation of cigarette smoke-induced lung inflammation: epigenetics in pathogenesis of COPD. Antioxid. Redox Signal. 10, 799-811
47. Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., Ueno, A., Oh-ishi, S., and Narumiya, S. (1997) Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388,678-682
48. Pittilo, R. M., Mackie, I. J., Rowles, P. M., Machin, S. J., and Woolf, N. (1982) Effects of cigarette smoking on the ultrastructure of rat thoracic aorta and its ability to produce prostacyclin. Thromb. Haemost. 48,173-176
49. Busacca, M., Balconi, G., Pietra, A., Vergara-Dauden, M., de Gaetano, G., and Dejana, E. (1984) Maternal smoking and prostacyclin production by cultured endothelial cells from umbilical arteries. Am. J. Obstet. Gynecol. 148, 1127-1130
50. Cipollone, F., Cicolini, G., and Bucci, M. (2008) Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives. Pharmacol. Ther. 118,161-180